Download Citation
Article Source:
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
Perico N,
Ruggenenti P,
Perna A,
Caroli A,
Trillini M,
et al.
(2019)
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.
PLOS Medicine 16(4): e1002777.
https://doi.org/10.1371/journal.pmed.1002777